All stocks Β· LINKPH
LP

Link Pharma Chem Ltd.

LINKPH BSE Chemicals Basic Materials

Link Pharma Chem Limited engages in the manufacturing and selling of drugs intermediates for pharmaceutical, agriculture, cosmetics, and veterinary Industries in India. It also engages in custom synthesis/contract manuf…

ISIN INE302F01011
Listed β€”
Quarters tracked 13
Filings 20 docs

About

Link Pharma Chem Limited engages in the manufacturing and selling of drugs intermediates for pharmaceutical, agriculture, cosmetics, and veterinary Industries in India. It also engages in custom synthesis/contract manufacturing for multistage synthesis for small, medium, and large companies; development of multistep pathways for organic synthesis; and refinement and optimization of existing synthetic methods. In addition, the company offers fragrance intermediates. Link Pharma Chem Limited was incorporated in 1984 and is based in Vadodara, India.

Key Metrics

as of Sep 2026
Market Cap12 Cr
P/Eβ€”
Div Yield0.00 %
Book Valueβ‚Ή28.80
52w Highβ‚Ή41.90
52w Lowβ‚Ή21.00
Face Valueβ‚Ή10.00

Quarterly Results

Rs. Crores Β· hover row for definition
Metric Jun 2026 Mar 2026 Dec 2025 Sep 2025 Jun 2025 Mar 2025 Dec 2024 Sep 2024 Jun 2024 Mar 2024 Dec 2023 Sep 2023 Jun 2023
Sales 8.77 6.59 6.73 6.29 7.81 6.45 5.34 4.80 8.85 8.03 7.94 6.05 7.88
Expenses 8.32 6.83 6.04 5.95 7.17 6.68 5.23 5.10 8.30 7.12 7.66 6.93 8.84
Operating Profit 0.45 -0.24 0.69 0.34 0.64 -0.23 0.11 -0.30 0.55 0.91 0.28 -0.88 -0.96
OPM % 5.13 -3.64 10.25 5.41 8.19 -3.57 2.06 -6.25 6.21 11.33 3.53 -14.55 -12.18
Other Income 0.35 0.15 -0.20 0.05 0.21 0.12 -0.56 0.36 0.27 -0.01 0.37 -0.03 0.31
Depreciation 0.27 0.25 0.25 0.25 0.24 0.24 0.24 0.24 0.24 0.25 0.27 0.26 0.26
Interest 0.14 0.15 0.14 0.13 0.10 0.14 0.21 0.21 0.22 0.19 0.23 0.22 0.23
Profit before tax 0.39 -0.49 0.10 0.01 0.51 -0.49 -0.90 -0.39 0.36 0.46 0.15 -1.39 -1.14
Tax % 17.95 -16.33 40.00 0.00 21.57 -26.53 -24.44 -20.51 16.67 45.65 -46.67 -26.62 -28.07
Net Profit 0.32 -0.41 0.07 0.02 0.40 -0.35 -0.67 -0.31 0.30 0.26 0.22 -1.02 -0.82
EPS in Rs 0.72 -0.92 0.16 0.05 0.90 -0.79 -1.51 -0.70 0.68 0.59 0.50 -2.30 -1.85

Profit & Loss

Annual Β· Rs. Crores
Metric Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015
Sales 27.4325.4329.9038.7653.5634.8125.4724.5023.5316.1012.3517.58
Expenses 25.9825.3030.5536.0450.0231.6722.0522.4820.7513.5612.1618.36
Operating Profit 1.450.13-0.652.723.543.143.422.022.782.540.19-0.78
OPM % 5.290.51-2.177.026.619.0213.438.2411.8115.781.54-4.44
Other Income 0.200.190.64-0.150.46-0.15-0.690.190.07-0.432.390.21
Interest 0.530.780.870.760.450.440.360.390.620.800.911.44
Depreciation 0.980.941.030.920.930.870.930.890.860.830.931.13
Profit before tax 0.14-1.40-1.910.892.621.681.440.931.370.480.74-3.14
Tax % 42.86-26.43-28.8026.9728.2435.1234.0329.0317.5254.1720.27-29.94
Net Profit 0.08-1.03-1.360.651.881.080.950.661.130.230.59-2.20
EPS in Rs 0.18-2.32-3.061.464.232.432.141.492.540.521.33-4.95
Dividend Payout % 0.000.000.000.000.000.000.000.000.000.000.000.00

Balance Sheet

Annual Β· Rs. Crores β€” latest first
Metric Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015
Equity Capital 4.444.444.444.444.444.444.444.444.444.444.444.44
Reserves 8.358.229.2710.6010.038.126.995.945.354.164.523.93
Borrowings 7.315.789.228.766.393.663.562.642.714.735.4110.80
Other Liabilities 4.874.863.028.668.109.823.984.994.693.813.467.35
Total Liabilities 24.9723.3025.9532.4628.9626.0418.9718.0117.1917.1417.8326.52
Fixed Assets 10.389.289.949.008.798.718.819.149.769.5710.1317.51
CWIP 0.000.000.000.000.210.000.000.430.010.000.000.00
Investments 2.472.062.933.644.520.030.030.030.030.030.020.02
Other Assets 12.1211.9613.0819.8215.4417.3010.138.417.397.547.688.99
Total Assets 24.9723.3025.9532.4628.9626.0418.9718.0117.1917.1417.8326.52

Cash Flows

Annual Β· Rs. Crores β€” latest first
Metric Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015
Cash from Operating Activity 2.152.69-0.03-1.71-1.264.842.951.363.792.23-3.915.13
Cash from Investing Activity -2.661.530.41-0.08-4.97-2.16-1.66-0.96-1.15-0.738.72-3.27
Cash from Financing Activity 0.99-4.21-0.411.612.27-0.330.55-0.46-2.63-1.48-5.75-0.87
Net Cash Flow 0.480.00-0.03-0.17-3.952.351.85-0.050.000.02-0.940.99
Free Cash Flow 0.052.43-0.86-2.60-2.013.131.270.492.631.374.801.84
CFO/OP % 150.002,046.00-52.00-48.00-17.00169.0083.0077.00147.0092.00-2,005.00-658.00

Ratios

Annual Β· Days / % β€” latest first
Metric Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015
Debtor Days 70.2672.0562.8734.1836.6058.1971.5145.2949.3349.4268.8663.74
Inventory Days 170.29166.94135.89209.2347.6851.3560.0492.5496.96285.97277.34125.34
Days Payable 110.59101.2138.51112.9045.37140.70110.86108.98124.25202.9381.6194.59
Cash Conversion Cycle 129.96137.78160.24130.5138.90-31.1620.6828.8522.05132.47264.5994.49
Working Capital Days -7.0515.075.1326.7414.1710.4951.4531.4331.640.23-6.80-46.92
ROCE % 3.48-3.00-4.796.7213.1614.6118.7110.3415.4113.00-3.64-8.74

Shareholding Pattern

% holding β€” latest first
Holder Jun 2026 Mar 2026 Dec 2025 Sep 2025 Jun 2025 Mar 2025 Dec 2024 Sep 2024 Jun 2024 Mar 2024 Dec 2023 Sep 2023
Promoters 52.40 52.40 51.49 51.49 51.49 51.49 51.49 51.49 51.49 51.49 51.49 51.49
DIIs 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.02
Public 47.58 47.59 48.49 48.49 48.50 48.49 48.50 48.49 48.49 48.50 48.50 48.49
No. of Shareholders 6,005 6,020 6,063 6,090 6,112 6,160 6,181 6,151 6,083 6,200 6,132 6,212